ArticleLife (Basel, Switzerland)2025

Efficacy and Safety of Selexipag Treatment in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension with Concomitant Interstitial Lung Disease.

Chebly Dagher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.